Skip to content

Randomized trial on the use of nasogastric and nasojejunal tubes (Ryle's tubes) after gastrectomy for cancer

Randomized trial on the use of nasogastric and nasojejunal tubes (Ryle's tubes) after gastrectomy for cancer

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003340
Enrollment
Unknown
Registered
2013-07-19
Start date
2013-08-02
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Two groups:Removal of nasogastric or nasojejunal tube in OT theatre after gastrectomy for cancer from end of operation to resumption of oral feeding, usually around 3 days versus keeping the nasogastr

Sponsors

Hospital authority
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective operations for gastric cancer; 2. Age of patients >=18 and <=80; 3. Patients are mentally fit to sign consent and understand the context of the study.

Exclusion criteria

Exclusion criteria: 1. There is clinical and radiological evidence of gastric outlet obstruction; 2. There is clinical and radiological evidence of intestinal obstruction; 3. The patient will exit from study if tumor is non-resectable at operation; 4. ASA >2.

Design outcomes

Primary

MeasureTime frame
Pulmonary complications rate;Degree of throat discomfort;need to insert NG or NJ tube in ward;postoperative length of stay;

Secondary

MeasureTime frame
Anastomotic leakage rate;Reoperation;Mortality;

Contacts

Public ContactLeung Siu Kee
drleungsk@hotmail.com+852 24685379

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026